Analyst firms · H.C. Wainwright · CRDF
H.C. Wainwright CRDF price target and rating history
Cardiff Oncology Inc. (CRDF) · Health Care
H.C. Wainwright rates Cardiff Oncology Inc. (CRDF) Buy with a $9 price target, as of its latest action on Sep 15, 2026. It has published 4 rating actions on CRDF since August 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a CRDF price target in the last 12 months, the median target is $9. H.C. Wainwright's target matches it.
- Current rating
- Buy
- Price target
- $9
- Median target, all firms
- $9
- Actions on CRDF
- 4
H.C. Wainwright price target on CRDF
Every H.C. Wainwright rating on CRDF
- Sep 15, 2026
- Jun 1, 2026
- Feb 28, 2022
- Aug 10, 2021
How other firms rate CRDF
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Buy | $9 | Sep 15, 2026 |
| William Blair | Mkt Perform | Aug 12, 2026 | |
| Craig-Hallum | Hold | $2 | Jun 3, 2026 |
| TD Cowen | Hold | Jun 1, 2026 | |
| Noble Capital Markets | Outperform | $12 | Jan 5, 2026 |
Questions about H.C. Wainwright and CRDF
- What is H.C. Wainwright's price target for CRDF?
- H.C. Wainwright's latest stated price target for Cardiff Oncology Inc. (CRDF) is $9, from its action on Sep 15, 2026.
- What is H.C. Wainwright's rating on CRDF?
- H.C. Wainwright rates CRDF Buy, a bullish rating, as of Sep 15, 2026.
- When did H.C. Wainwright last change its view on CRDF?
- On Sep 15, 2026, H.C. Wainwright upgrades to Buy from Neutral, price target $9.
- How does H.C. Wainwright's CRDF target compare with other analysts?
- Across 3 firms with a CRDF price target in the last 12 months, the median target is $9. H.C. Wainwright's target matches it.
All H.C. Wainwright ratingsCRDF news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.